Armotraz 1 Mg Tablet

About Armotraz 1 Mg Tablet

Armotraz 1 mg tablet contains anastrozole, which is an aromatase inhibitor used primarily in the treatment of breast cancer. It works by reducing the amount of estrogen in the body, which can help slow or stop the growth of estrogen-dependent breast cancer cells.

Common uses of Armotraz (anastrozole):

1. Breast cancer: Armotraz is often used in postmenopausal women with estrogen receptor-positive (ER-positive) breast cancer. It is typically used after surgery, radiation, or chemotherapy to reduce the risk of cancer recurrence.
2. Advanced breast cancer: It may also be used to treat advanced or metastatic breast cancer in postmenopausal women when other treatments are not effective.

How it works:

Anastrozole works by inhibiting the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogen. By reducing estrogen production, anastrozole helps limit the growth of estrogen-driven breast cancer cells.

Common side effects of Armotraz:

• Hot flashes or night sweats
• Joint pain or muscle aches
• Nausea or vomiting
• Fatigue
• Headaches
• Bone thinning (osteoporosis), leading to an increased risk of fractures
• Mood changes or depression
• Increased cholesterol levels

Important considerations:

• Bone health: Since anastrozole can lead to bone thinning, your doctor may monitor bone mineral density and may recommend calcium or vitamin D supplements to help maintain bone strength.
• Liver function: Liver function should be monitored as anastrozole can affect liver enzymes.
• Pregnancy: Armotraz should not be taken during pregnancy, as it could harm the developing fetus. It is also not recommended for use in premenopausal women.
• Drug interactions: Make sure to inform your doctor about any other medications you are taking, as there can be interactions with other drugs.

Anastrozole is a commonly used medication in the treatment of hormone receptor-positive breast cancer, and while effective, it is important to manage and monitor for side effects during treatment. Regular follow-up with your healthcare provider is essential to monitor your response to the medication.

Targeted Therapy for Breast Cancer

Armotraz 1 mg Tablet is indicated for hormone receptor-positive breast cancer in postmenopausal women. By inhibiting the enzyme aromatase, it significantly decreases estrogen levels in the body, thus preventing the growth of certain types of breast cancer cells. This precise mechanism makes Armotraz an essential component in modern hormone therapy.


Easy-to-Use Oral Formulation

Armotraz tablets feature a small, film-coated, round design, making them easy to swallow. The solid oral dosage formulation provides accurate dosing and convenient daily use, underlining its suitability for long-term treatment plans prescribed by oncologists.


Quality Assurance and Safe Handling

Produced in accordance with pharmaceutical-grade standards, Armotraz is supplied in unopened, tamper-proof blister packs. This attention to quality ensures medication efficacy and patient safety. The shelf life extends up to 36 months when stored correctly, providing stability and reliability for both patients and healthcare providers.